Chargement en cours...
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
SIMPLE SUMMARY: Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling is associated with an increased risk of thromboembolic and bleeding complications in cancer patients and may cause fatal side effects. The multityrosine kinase inhibitor sorafenib represents an important trea...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7602103/ https://ncbi.nlm.nih.gov/pubmed/33066190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102961 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|